Giorgio Sesti

Pubblicazioni

Titolo Pubblicato in Anno
Association between liver fibrosis and decreased myocardial mechano-energetic efficiency in individuals with different degree of glucose tolerance DIABETES RESEARCH AND CLINICAL PRACTICE 2023
Low-density lipoprotein cholesterol levels are associated with first-phase insulin release DIABETES RESEARCH AND CLINICAL PRACTICE 2023
Clinical implications of the biological ambivalence of uric acid EUROPEAN JOURNAL OF INTERNAL MEDICINE 2023
Prescribing trends of glucose-lowering drugs in older adults from 2010 to 2021: a population-based study of Northern Italy DIABETES RESEARCH AND CLINICAL PRACTICE 2023
A bedside ultrasound protocol to the measurement of the systemic vascular resistances: Preliminary results in the patients with sepsis CLINICAL HEMORHEOLOGY AND MICROCIRCULATION 2023
Metabolic syndrome and C reactive protein are associated with a reduced myocardial mechano-energetic efficiency THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2023
Higher circulating levels of proneurotensin are associated with increased risk of incident NAFLD JOURNAL OF INTERNAL MEDICINE 2023
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation FRONTIERS IN PHARMACOLOGY 2023
New potential biomarkers for early chronic kidney disease diagnosis in patients with different glucose tolerance status FRONTIERS IN ENDOCRINOLOGY 2023
One-hour post-load glucose and subclinical left atrial myocardial dysfunction in hypertensive patients EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2023
Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2023
Osteopontin levels correlate with severity of diabetic cardiomyopathy in early stage of diabetes DIABETES RESEARCH AND CLINICAL PRACTICE 2023
The measurement of the left ventricle ejection fraction by a bedside FoCUS examination INTERNAL AND EMERGENCY MEDICINE 2023
Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Liver fibrosis is associated with an increased risk of non-fatal myocardial infarction EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2023
Endothelial dysfunction is associated with reduced myocardial mechano-energetic efficiency in drug-naïve hypertensive individuals INTERNAL AND EMERGENCY MEDICINE 2023
Low dose aspirin and clinical outcomes in patients with SARS-CoV-2 pneumonia: a propensity score-matched cohort analysis from the National SIMI‑COVID‑19 Registry INTERNAL AND EMERGENCY MEDICINE 2023
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine VACCINES 2023
Clinical evaluation of bempedoic acid for the treatment of hyperlipidaemia NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES 2022
The Functional Polymorphism of DDAH2 rs9267551 Is an Independent Determinant of Arterial Stiffness FRONTIERS IN CARDIOVASCULAR MEDICINE 2022

ERC

  • LS4_9
  • LS4_10

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

- Meccanismi molecolari dell’azione insulinica e della funzione pancreatica;

- Fisiopatologia del diabete tipo 2 e dell’obesità;

- Genetica dell’insulino-resistenza, del diabete tipo 2 e dell’obesità;

- Sindrome metabolica e prediabete;

- Obesità metabolicamente sana;

- Trattamento del diabete tipo 2;

- Ruolo dell’IGF-1 nella patologia cardiovascolare e metabolica;

- Infiammazione, disfunzione endoteliale e patologia cardiovascolare;

- Epatopatie croniche e danno cardio-metabolico

Keywords

Diabetes Mellitus
obesity
cardiovascular disease

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma